Sernova Biotherapeutics Inc. (OTCMKTS:SEOVF) Short Interest Down 35.0% in June

Sernova Biotherapeutics Inc. (OTCMKTS:SEOVF) saw a large decrease in short interest in the month of June. As of June 15th, there was short interest totaling 130,922 shares, a decrease of 35.0% from the May 31st total of 201,477 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 48,613 shares, the days-to-cover ratio is presently 2.7 days.

Sernova Biotherapeutics Trading Up 3.6%

Shares of SEOVF stock opened at $0.10 on Thursday. Sernova Biotherapeutics has a 12-month low of $0.07 and a 12-month high of $0.16. The business’s 50 day moving average is $0.11 and its two-hundred day moving average is $0.11. The company has a market capitalization of $39.12 million, a P/E ratio of -2.59 and a beta of 0.82.

Sernova Biotherapeutics (OTCMKTS:SEOVF) last posted its quarterly earnings data on Thursday, June 11th. The company reported ($0.01) EPS for the quarter, meeting analysts’ consensus estimates of ($0.01).

Sernova Biotherapeutics Company Profile

Sernova Biotherapeutics is a clinical‐stage biotechnology company focused on developing and commercializing cell‐based therapeutic technologies for patients with chronic and life‐threatening diseases. Headquartered in London, Ontario, Canada, the firm is advancing an implantable device platform designed to support the long-term survival and function of therapeutic cells. The company’s lead product candidate, known as the Cell Pouch System, is engineered to create a vascularized environment in which transplanted cells can thrive, with an initial emphasis on treating patients with type 1 diabetes.

In its core program, Sernova has initiated a Phase I/II clinical trial evaluating the safety and efficacy of the Cell Pouch System in individuals with type 1 diabetes who require islet cell transplantation.